Details for Patent: 9,993,471
✉ Email this page to a colleague
Which drugs does patent 9,993,471 protect, and when does it expire?
Patent 9,993,471 protects ZERVIATE and is included in one NDA.
This patent has twenty-three patent family members in seven countries.
Summary for Patent: 9,993,471
| Title: | Ophthalmic formulations of cetirizine and methods of use |
| Abstract: | The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye. |
| Inventor(s): | Abelson; Mark Barry (Andover, MA), Chapin; Matthew J. (Amesbury, MA), Gomes; Paul (Andover, MA), Minno; George (Windham, NH), Nice; Jackie (Medford, MA) |
| Assignee: | NICOX OPHTHALMICS, INC. (Fort Worth, TX) |
| Application Number: | 15/456,249 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,993,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,993,471
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2755679 | ⤷ Sign Up | |||
| European Patent Office | 2408453 | ⤷ Sign Up | |||
| European Patent Office | 2547340 | ⤷ Sign Up | |||
| European Patent Office | 3943069 | ⤷ Sign Up | |||
| Spain | 2910374 | ⤷ Sign Up | |||
| Japan | 2012520882 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
